{"version":"1.0","type":"link","title":"A systematic review and meta-analysis of cardiovascular disease risk with degarelix and GnRH agonists in prostate cancer.","author_name":"de Moraes FCA 외","author_url":"https://prs-insight.online/author/de%20Moraes%20FCA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138693","thumbnail_width":1200,"thumbnail_height":630}